News

LabTrace Completes First Study Using Its Blockchain-Based Data Authentication System, Designed to Ensure Data Integrity in Clinical Trials

Published

on

Parkinson’s disease research, sponsored by King’s College London, verifies clinical observation data using Algorand blockchain

LONDON, June 27, 2024 /PRNewswire/ — LabTracea blockchain authentication system for data integrity and ownership certification, today announces the completion of the first experimental medicine study (ref ID: NCT03782753) to use its on-chain authentication tool, a new solution for proving the provenance of medical research data. The study, sponsored by King’s College London (KCL), involved patients with Parkinson’s disease. Using the Algorand blockchain, LabTrace introduced unprecedented transparency, accountability, and security to the verification of scientific research data.

There is growing concern that the exponential expansion of digital data in healthcare and medical research is accompanied by a growing incidence of scientific fraud. Second The Guardian, in 2023 “the annual number of articles retracted from research journals exceeded 10,000 for the first time” and “most analysts believe this figure is just the tip of an iceberg of scientific fraud.” One reason given for the increase in falsified data is the pressure to generate successful, high-impact results, which offer researchers greater recognition and career advancement opportunities.

“Progress in science and medicine depends critically on the quality of the data collected in our research studies, and we take this responsibility very seriously,” said Professor Steve Williams, director of the Center of Neuroimaging Science at King’s College London and principal investigator of the study. . “The integrity of research data is the foundation of medical discoveries, and LabTrace’s blockchain-based system gives us the level of transparency we need to trust, track and authenticate our data.”

LabTrace’s blockchain-based data authentication system offers a unique and transparent solution for:

  • Certify the authorship and provenance of the data
  • Establish and record a researcher’s ownership rights in data and discoveries
  • Securely timestamp and record trial data, original work, ideas and inventions in a verifiable manner
  • Support drug approvals and patent applications
  • Protect yourself from intellectual property and data theft

This is done by attaching unique Content IDs (CIDs), which follow IPFS standards, to all recorded data. Each CID file receives on-chain authentication from authorized parties, with user permissions defined and controlled by an Algorand smart contract (i.e. role-based access control). KCL implemented LabTrace as an additional layer of immutable record keeping and to demonstrate a viable path to maintaining the integrity of digital medical data.

After examining the blockchain landscape, LabTrace determined that Algorand, a leading Layer 1 solution known for its high performance and reliability, was best suited to meet the rigorous requirements of the biotech and pharmaceutical industries. The specific advantages of Algorand are:

  • Its Layer-1 smart contract programmability, which enables role-based access control
  • High processing speed of 10,000 transactions (or on-chain records) per second
  • High certainty and instant finality of the transaction, which provides an immediate and immutable guarantee of the information recorded in the register.

It is possible to view the timestamps and authenticated authentications that certify the results of the process Here.

“This is a major achievement for our company, as it demonstrates that our solution can be easily adopted in experimental medicine studies, managing data of any type,” said Federico Turkheimer, professor at King’s College London and director of LabTrace. “We believe we have created a solution to enable full traceability of data in clinical trials and increase scientific reproducibility in medical research.”

“With artificial intelligence expanding the scope and sophistication of potential data manipulation and fraud, it is more important than ever that researchers, regulators and the public have reliable data sources,” said Eric Wragge, global head of business and capital markets development for industry. Algorand Foundation. “Accurate data is the foundation of scientific progress everywhere, and we are honored that Algorand is the blockchain on which the Labtrace solution was built.”

About LabTrace
LabTrace believes that certified and verifiable data is the core of a trusted digital society. The company’s mission is to enable full data traceability in clinical trials and increase scientific reproducibility in medical research. To further this goal, LabTrace has created a blockchain-based system for secure, GDPR-compliant, immutable authentication of digital data. For more information visit www.labtrace.io.

About the Algorand Foundation
Algorand’s mission is to power a world where information is whole and innovative ideas can thrive. The Algorand Foundation supports Algorand’s rapidly growing ecosystem by providing a world-class development environment, supporting key infrastructure and defining technical standards, offering comprehensive support to builders and entrepreneurs, and providing the infrastructure for decentralized governance.

Founded by Turing Award-winning cryptographer Silvio Micali in 2019, Algorand has grown into a vibrant ecosystem of developers, entrepreneurs, and corporate partners who benefit from institutional-grade certainty and resilience, while features like low fees, instant finality, and a minimal of carbon emissions The footprint also appeals to the protocol’s millions of retail users. Builders of all types can use common programming languages ​​like Python to develop advanced apps and protocols that solve important problems on a global scale: instant payments in war zones and disasters, self-sovereign identity for the disenfranchised, chain tracing supply for global trade, permissionless protocols addressing financial inclusion, and the creation of entirely new markets through tokenization, to name a few. To learn more and begin your Algorand journey, visit foundation.algorand.

SOURCE Algorand Foundation

Fuente

Leave a Reply

Your email address will not be published. Required fields are marked *

Información básica sobre protección de datos Ver más

  • Responsable: Miguel Mamador.
  • Finalidad:  Moderar los comentarios.
  • Legitimación:  Por consentimiento del interesado.
  • Destinatarios y encargados de tratamiento:  No se ceden o comunican datos a terceros para prestar este servicio. El Titular ha contratado los servicios de alojamiento web a Banahosting que actúa como encargado de tratamiento.
  • Derechos: Acceder, rectificar y suprimir los datos.
  • Información Adicional: Puede consultar la información detallada en la Política de Privacidad.

Trending

Exit mobile version